Private Trust Company’s Verona Pharma VRNA Stock Holding History

Private Trust Company’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-169	Closed	-$18K	–	2678
2025 Q3	$18K	Sell	169 -25	-13%	-$2.61K	﹤0.01%	1685
2025 Q2	$18.3K	Sell	194 -56	-22%	-$4.15K	﹤0.01%	1608
2025 Q1	$15.9K	Buy	250 +77	+45%	+$4.61K	﹤0.01%	1647
2024 Q4	$8.03K	Hold	173	–	–	﹤0.01%	1825
2024 Q3	$4.98K	Hold	173	–	–	﹤0.01%	1952
2024 Q2	$2.5K	Buy	173 +56	+48%	+$818	﹤0.01%	2122
2024 Q1	$1.88K	Hold	117	–	–	﹤0.01%	2119
2023 Q4	$2.33K	Buy	+117	New	+$1.73K	﹤0.01%	2110

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Private Trust Company's VRNA Position: Q4 2025 in Review

Private Trust Company sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 169 shares — an estimated $18K sold.

Private Trust Company first reported a position in VRNA in Q4 2023 and held it in 8 quarters. The position peaked at $18.3K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Private Trust Company reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Private Trust Company sold 169 Verona Pharma shares in Q4 2025, an estimated $18K.
Private Trust Company first reported a position in Verona Pharma in Q4 2023 and held it in 8 quarters.
Private Trust Company's Verona Pharma position peaked at $18.3K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.